Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.

NCT06574087 is registered in ClinicalTrials.gov with PCK Marine Hospital in Gdynia as lead sponsor.

NCT NCT06574087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06574087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.
Lead sponsor
PCK Marine Hospital in Gdynia
Phase
Not applicable
Overall status
Recruiting
Start date
January 13, 2023
Completion date
January 31, 2027
Enrollment
248 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hpv infection, hpv-related carcinoma